Fiorino Anthony S. Insider Trades

Insider Trading History

Track insider trading activity for Fiorino Anthony S.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
Director
Holding Value $0 0 shares
Last Trade
Feb 03, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$323 75,000 shares
$0.00
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
Director
Holding Value $75 75,000 shares
Last Trade
May 22, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$98k 25,000 shares
$3.92
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
Director
Holding Value $50 50,000 shares
Last Trade
May 17, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$196k 50,000 shares
$3.92
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
Director
Holding Value $90 90,000 shares
Last Trade
Sep 14, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$353k 90,000 shares
$3.92
$0.00
Navidea Biopharmaceuticals
Navidea Biopharmaceuticals NAVB
Director
Holding Value $7.8 78,000 shares
Last Trade
Jun 30, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.02M 100,000 shares
$10.20
$0.00
Navidea Biopharmaceuticals
Navidea Biopharmaceuticals NAVB
Director
Holding Value $2.8 28,000 shares
Last Trade
Apr 20, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$734k 28,000 shares
$26.20
$0.00
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Chief Executive Officer
Holding Value $2.28k 2,500 shares
Last Trade
Oct 15, 2014 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$25.9k 500 shares
$51.75
$0.91
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Chief Executive Officer
Holding Value $1.82k 2,000 shares
Last Trade
Sep 18, 2014 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$46.1k 800 shares
$57.60
$0.91
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Chief Executive Officer
Holding Value $16.4k 18,000 shares
Last Trade
Sep 15, 2014 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$508k 8,000 shares
$63.53
$0.91
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Chief Executive Officer
Holding Value $9.1k 10,000 shares
Last Trade
Sep 12, 2014 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$641k 10,000 shares
$64.09
$0.91
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Chief Executive Officer
Holding Value $5.19M 5,700,000 shares
Last Trade
Jun 09, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$383M 5,700,000 shares
$67.24
$0.91

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up